134 related articles for article (PubMed ID: 38367850)
1. DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.
Lyden SP; Soukas PA; De A; Tedder B; Bowman J; Mustapha JA; Armstrong EJ;
J Vasc Surg; 2024 Jun; 79(6):1420-1427.e2. PubMed ID: 38367850
[TBL] [Abstract][Full Text] [Related]
2. One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass.
Krievins DK; Halena G; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Nair K; Holden A; Schmidt A
J Vasc Surg; 2020 Nov; 72(5):1648-1658.e2. PubMed ID: 32276015
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System.
Halena G; Krievins DK; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Schmidt A; Zdunek M; Lyden SP
J Endovasc Ther; 2022 Feb; 29(1):84-95. PubMed ID: 34465223
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
6. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
[No Abstract] [Full Text] [Related]
7. The DETOUR procedure: no more need for conventional bypass surgery?
Krievins D; Savlovskis J; Ezite N; Hill A; Kisis K; Gedins M; Zellans E; Holden A
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):172-177. PubMed ID: 29327570
[TBL] [Abstract][Full Text] [Related]
8. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
9. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
Owens CD; Gasper WJ; Walker JP; Alley HF; Conte MS; Grenon SM
J Vasc Surg; 2014 Apr; 59(4):1016-24. PubMed ID: 24423476
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Femoropopliteal Lesions With the BioMimics 3D Vascular Stent System: Two-Year Results From the MIMICS-2 Trial.
Sullivan TM; Zeller T; Nakamura M; Gaines PA;
J Endovasc Ther; 2021 Apr; 28(2):236-245. PubMed ID: 33331207
[TBL] [Abstract][Full Text] [Related]
13. Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
Laird JR; Zeller T; Loewe C; Chamberlin J; Begg R; Schneider PA; Nanjundappa A; Bunch F; Schultz S; Harlin S; Lansky A; Jaff MR
J Endovasc Ther; 2018 Feb; 25(1):68-78. PubMed ID: 29285955
[TBL] [Abstract][Full Text] [Related]
14. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
[TBL] [Abstract][Full Text] [Related]
15. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.
Garcia L; Jaff MR; Metzger C; Sedillo G; Pershad A; Zidar F; Patlola R; Wilkins RG; Espinoza A; Iskander A; Khammar GS; Khatib Y; Beasley R; Makam S; Kovach R; Kamat S; Leon LR; Eaves WB; Popma JJ; Mauri L; Donohoe D; Base CC; Rosenfield K;
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969545
[TBL] [Abstract][Full Text] [Related]
16. 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Nerla R; Vadalà G; Castriota F; Grattoni C; Liso A; Russo P; Pantaleo P; Roscitano G; Cremonesi A
JACC Cardiovasc Interv; 2017 Apr; 10(7):728-734. PubMed ID: 28385412
[TBL] [Abstract][Full Text] [Related]
17. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
18. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).
Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
J Endovasc Ther; 2024 Jun; 31(3):400-409. PubMed ID: 36146948
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study.
Bunte MC; Cohen DJ; Jaff MR; Gray WA; Magnuson EA; Li H; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Patarca R; Du J; Stoll HP; Massaro J; Safley DM;
Catheter Cardiovasc Interv; 2018 Jul; 92(1):106-114. PubMed ID: 29521013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]